INS and myotonic dystrophy type 2: This profile mimics a progressive loss of glucose-stimulated insulin secretion in humans suffering from DM2, and hence, ZDF rats represent the best laboratory model to study human DM2, its pathophysiology, and the effects of potential therapeutic options [11,12,13].